vs
CapsoVision, Inc（CV）与electroCore, Inc.（ECOR）财务数据对比。点击上方公司名可切换其他公司
electroCore, Inc.的季度营收约是CapsoVision, Inc的2.6倍（$9.2M vs $3.5M）。electroCore, Inc.净利率更高（-32.8% vs -223.9%，领先191.0%）
CapsoVision, Inc.是一家医疗科技企业，专注研发、生产先进胶囊内窥镜系统及配套诊断解决方案，旗下非侵入式胃肠道成像产品供应全球多地的医院、消化科诊所及医疗专业人员，助力提升消化道疾病检测准确率与患者诊疗体验。
electroCore是一家总部位于美国新泽西州巴斯金里奇的医疗科技公司，于2005年由四位联合创始人创立，现任首席执行官为Daniel S. Goldberger。公司主打产品为gammaCore，是一款已实现商业化的非侵入式设备，通过迷走神经刺激发挥作用。
CV vs ECOR — 直观对比
营收规模更大
ECOR
是对方的2.6倍
$3.5M
净利率更高
ECOR
高出191.0%
-223.9%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $3.5M | $9.2M |
| 净利润 | $-7.9M | $-3.0M |
| 毛利率 | 54.1% | 88.4% |
| 营业利润率 | -226.7% | -31.8% |
| 净利率 | -223.9% | -32.8% |
| 营收同比 | — | 31.2% |
| 净利润同比 | — | 6.0% |
| 每股收益（稀释后） | $-0.17 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVECOR
| Q4 25 | — | $9.2M | ||
| Q3 25 | $3.5M | $8.7M | ||
| Q2 25 | $3.3M | $7.4M | ||
| Q1 25 | — | $6.7M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $6.1M | ||
| Q1 24 | — | $5.4M |
净利润CVECOR
| Q4 25 | — | $-3.0M | ||
| Q3 25 | $-7.9M | $-3.4M | ||
| Q2 25 | $-4.6M | $-3.7M | ||
| Q1 25 | — | $-3.9M | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $-2.7M | ||
| Q1 24 | — | $-3.5M |
毛利率CVECOR
| Q4 25 | — | 88.4% | ||
| Q3 25 | 54.1% | 86.0% | ||
| Q2 25 | 54.6% | 87.3% | ||
| Q1 25 | — | 84.9% | ||
| Q4 24 | — | 85.9% | ||
| Q3 24 | — | 83.8% | ||
| Q2 24 | — | 86.3% | ||
| Q1 24 | — | 83.7% |
营业利润率CVECOR
| Q4 25 | — | -31.8% | ||
| Q3 25 | -226.7% | -33.2% | ||
| Q2 25 | -140.3% | -47.5% | ||
| Q1 25 | — | -56.9% | ||
| Q4 24 | — | -43.6% | ||
| Q3 24 | — | -40.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | -70.7% |
净利率CVECOR
| Q4 25 | — | -32.8% | ||
| Q3 25 | -223.9% | -39.2% | ||
| Q2 25 | -139.5% | -49.7% | ||
| Q1 25 | — | -57.4% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | — | -38.1% | ||
| Q2 24 | — | -43.2% | ||
| Q1 24 | — | -64.4% |
每股收益（稀释后）CVECOR
| Q4 25 | — | $-0.34 | ||
| Q3 25 | $-0.17 | $-0.40 | ||
| Q2 25 | $-2.02 | $-0.44 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-0.37 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.38 | ||
| Q1 24 | — | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $11.6M |
| 总债务越低越好 | — | $7.8M |
| 股东权益账面价值 | $20.4M | $-1.7M |
| 总资产 | $25.7M | $18.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVECOR
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $13.0M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | — | $12.9M | ||
| Q2 24 | — | $14.2M | ||
| Q1 24 | — | $7.8M |
总债务CVECOR
| Q4 25 | — | $7.8M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CVECOR
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $20.4M | $-1.1M | ||
| Q2 25 | $-139.0M | $1.1M | ||
| Q1 25 | — | $4.4M | ||
| Q4 24 | — | $7.5M | ||
| Q3 24 | — | $9.5M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | — | $4.5M |
总资产CVECOR
| Q4 25 | — | $18.7M | ||
| Q3 25 | $25.7M | $21.4M | ||
| Q2 25 | $9.5M | $14.6M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $20.5M | ||
| Q3 24 | — | $21.0M | ||
| Q2 24 | — | $22.4M | ||
| Q1 24 | — | $13.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $-5.7M | — |
| 自由现金流率自由现金流/营收 | -160.5% | — |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CVECOR
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-5.7M | $-1.7M | ||
| Q2 25 | $-9.5M | $-623.0K | ||
| Q1 25 | — | $-4.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.8M | ||
| Q1 24 | — | $-2.6M |
自由现金流CVECOR
| Q4 25 | — | — | ||
| Q3 25 | $-5.7M | $-1.7M | ||
| Q2 25 | $-9.6M | $-648.0K | ||
| Q1 25 | — | $-4.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CVECOR
| Q4 25 | — | — | ||
| Q3 25 | -160.5% | -19.3% | ||
| Q2 25 | -289.0% | -8.8% | ||
| Q1 25 | — | -65.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CVECOR
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 2.1% | 0.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
